A detailed history of Cwm, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Cwm, LLC holds 264 shares of RVMD stock, worth $14,908. This represents 0.0% of its overall portfolio holdings.

Number of Shares
264
Previous 231 14.29%
Holding current value
$14,908
Previous $9,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$36.92 - $47.94 $1,218 - $1,582
33 Added 14.29%
264 $12,000
Q2 2024

Jul 09, 2024

BUY
$30.14 - $40.68 $2,139 - $2,888
71 Added 44.38%
231 $9,000
Q4 2023

Feb 01, 2024

BUY
$18.35 - $34.12 $532 - $989
29 Added 22.14%
160 $5,000
Q3 2023

Oct 11, 2023

BUY
$25.17 - $35.05 $276 - $385
11 Added 9.17%
131 $4,000
Q2 2023

Aug 03, 2023

BUY
$20.28 - $27.0 $2,311 - $3,078
114 Added 1900.0%
120 $3,000
Q1 2023

Apr 28, 2023

BUY
$20.76 - $30.09 $124 - $180
6 New
6 $0

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $4.95B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.